These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7723404)

  • 1. Interferon-gamma inhibits apoptosis induced by wild-type p53, cytotoxic anti-cancer agents and viability factor deprivation in myeloid cells.
    Lotem J; Sachs L
    Leukemia; 1995 Apr; 9(4):685-92. PubMed ID: 7723404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of sequence-specific transactivation and p53-regulated apoptosis in interleukin 3-dependent hematopoietic cells.
    Gottlieb E; Lindner S; Oren M
    Cell Growth Differ; 1996 Mar; 7(3):301-10. PubMed ID: 8838860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53-independent apoptosis induced by genistein in lung cancer cells.
    Lian F; Li Y; Bhuiyan M; Sarkar FH
    Nutr Cancer; 1999; 33(2):125-31. PubMed ID: 10368806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of sensitivity to induction of apoptosis in myeloid leukemic cells by differentiation and bcl-2 dependent and independent pathways.
    Lotem J; Sachs L
    Cell Growth Differ; 1994 Mar; 5(3):321-7. PubMed ID: 7517174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chimeric E2A-HLF transcription factor abrogates p53-induced apoptosis in myeloid leukemia cells.
    Altura RA; Inukai T; Ashmun RA; Zambetti GP; Roussel MF; Look AT
    Blood; 1998 Aug; 92(4):1397-405. PubMed ID: 9694729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gamma interferon-inducible protein 10 induces HeLa cell apoptosis through a p53-dependent pathway initiated by suppression of human papillomavirus type 18 E6 and E7 expression.
    Zhang HM; Yuan J; Cheung P; Chau D; Wong BW; McManus BM; Yang D
    Mol Cell Biol; 2005 Jul; 25(14):6247-58. PubMed ID: 15988033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.
    Jiang XH; Wong BC; Lin MC; Zhu GH; Kung HF; Jiang SH; Yang D; Lam SK
    Oncogene; 2001 Nov; 20(55):8009-18. PubMed ID: 11753684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of apoptosis in hematopoiesis and leukemia by cytokines, tumor suppressor and oncogenes.
    Lotem J; Sachs L
    Leukemia; 1996 Jun; 10(6):925-31. PubMed ID: 8667646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated expression of p53 or p21 in a papillary serous endometrial carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death: potential application of gene therapy to endometrial cancer.
    Ramondetta L; Mills GB; Burke TW; Wolf JK
    Clin Cancer Res; 2000 Jan; 6(1):278-84. PubMed ID: 10656459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function.
    Kokontis JM; Wagner AJ; O'Leary M; Liao S; Hay N
    Oncogene; 2001 Feb; 20(6):659-68. PubMed ID: 11313999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 independent G0/G1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells.
    Shao ZM; Dawson MI; Li XS; Rishi AK; Sheikh MS; Han QX; Ordonez JV; Shroot B; Fontana JA
    Oncogene; 1995 Aug; 11(3):493-504. PubMed ID: 7630633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to apoptosis induced by alkylating agents in v-Ha-ras-transformed cells due to defect in p53 function.
    Kuo ML; Chou YW; Chau YP; Huang TS
    Mol Carcinog; 1997 Apr; 18(4):221-31. PubMed ID: 9142217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte-colony stimulating factor induced apoptosis in radiation-induced murine leukemia cell line.
    Handa A; Kashimura T; Kawano N; Yamamoto A; Yoshida S; Jinnai I; Murohashi I; Bessho M; Hirashima K
    Leukemia; 1997 Apr; 11 Suppl 3():387-8. PubMed ID: 9209400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knock-in mice with a chimeric human/murine p53 gene develop normally and show wild-type p53 responses to DNA damaging agents: a new biomedical research tool.
    Luo JL; Yang Q; Tong WM; Hergenhahn M; Wang ZQ; Hollstein M
    Oncogene; 2001 Jan; 20(3):320-8. PubMed ID: 11313961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
    Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
    Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.
    Ramirez PT; Gershenson DM; Tortolero-Luna G; Ramondetta LM; Fightmaster D; Wharton JT; Wolf JK
    Gynecol Oncol; 2001 Dec; 83(3):543-8. PubMed ID: 11733969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue specific expression of p53 target genes suggests a key role for KILLER/DR5 in p53-dependent apoptosis in vivo.
    Burns TF; Bernhard EJ; El-Deiry WS
    Oncogene; 2001 Aug; 20(34):4601-12. PubMed ID: 11498783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-1 beta-converting enzyme mediates cisplatin-induced apoptosis in malignant glioma cells.
    Kondo S; Barna BP; Morimura T; Takeuchi J; Yuan J; Akbasak A; Barnett GH
    Cancer Res; 1995 Dec; 55(24):6166-71. PubMed ID: 8521409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53-independent apoptosis associated with c-Myc-mediated block in myeloid cell differentiation.
    Amanullah A; Liebermann DA; Hoffman B
    Oncogene; 2000 Jun; 19(26):2967-77. PubMed ID: 10871848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth inhibition and activation of apoptotic gene expression by human chorionic gonadotropin in human breast epithelial cells.
    Srivastava P; Russo J; Mgbonyebi OP; Russo IH
    Anticancer Res; 1998; 18(6A):4003-10. PubMed ID: 9891438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.